Cardiovascular And Metabolic Risk In Patients With Chronic Myeloid Leukemia In Chronic Phase Receiving First-Line Bcr-Abl1 Tyrosine Kinase Inhibitors In The United States: Baseline And Six-Month Follow-Up Results From A Prospective Real-World Observational Study
BLOOD(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络